Quality indicators in inflammatory bowel disease
Sameer K. Berry, Gil Y. Melmed
Intest Res. 2018;16(1):43-47.   Published online 2018 Jan 18     DOI: https://doi.org/10.5217/ir.2018.16.1.43
Citations to this article as recorded by Crossref logo
Improving the quality of care for inflammatory bowel disease
Byong Duk Ye, Simon Travis
Intestinal Research.2019; 17(1): 45.     CrossRef
Regional variations in the use of biologics and immunomodulators among Korean patients with inflammatory bowel diseases
Minkyung Han, Yoon Suk Jung, Jae Hee Cheon, Sohee Park
Journal of Gastroenterology and Hepatology.2019;[Epub]     CrossRef
Medication non-adherence in inflammatory bowel diseases is associated with disability
Jonathan Perry, Andy Chen, Viraj Kariyawasam, Glen Collins, Chee Choong, Wei Ling Teh, Nikola Mitrev, Friedbert Kohler, Rupert Wing Loong Leong
Intestinal Research.2018; 16(4): 571.     CrossRef
Increased end-stage renal disease risk in patients with inflammatory bowel disease: A nationwide population-based study
Seona Park, Jaeyoung Chun, Kyung-Do Han, Hosim Soh, Kookhwan Choi, Ji Hye Kim, Jooyoung Lee, Changhyun Lee, Jong Pil Im, Joo Sung Kim
World Journal of Gastroenterology.2018; 24(42): 4798.     CrossRef